PubMed2 min read
Design, reporting, and research focus of neurology and psychiatry drug trials (2020-2023): a registry-based meta-epidemiological study using ClinicalTrials.gov and NLP
CONCLUSIONS: Registered neurology and psychiatry drug trials show persistent limitations in design and results reporting despite two decades of registry requirements.
By Simona Emilova DonevaPubMed - AI Research
Read the full story
Originally published by PubMed - AI Research on Oct 23, 2026.
Comments
Sign in to join the discussion.